A $3.3 million study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop eye problems and be at risk for future vision loss.
Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option.
January 27, 2024